Skip to main content

Month: March 2026

Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors

WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of global investment, trading, and executive leadership experience to support Streamex’s strategic growth, capital markets initiatives, and governance. He is joining as an independent director. Morgan Lekstrom, Co-Founder & Executive Chairman of Streamex said, “Shawn joins Streamex at a critical growth juncture bringing 30 years of high growth capital markets experience and connections...

Continue reading

Olenox Industries Kicks Off 2026 with 10-Well Drilling Program

Relicensing of Company’s 162-mile pipe is also proceeding CONROE, Texas, March 03, 2026 (GLOBE NEWSWIRE) — via IBN — Olenox Industries Inc. (NASDAQ: OLOX) (“Olenox” or the “Company”), a multifaceted energy company, is pleased to announce its 2026 drilling program is underway with the identification of well locations and plans to begin shooting seismic data this month. Olenox’s plans include drilling one well by the end of the current calendar quarter, followed by drilling three wells in each of the second, third and fourth calendar quarters of 2026. “We believe that due to the positive trends in oil prices, the time to kick off our drilling program is now,” said Olenox CEO Michael McLaren, noting the Company is continuing its efforts to bring wells online on a weekly basis through workovers and lease enhancements. Olenox...

Continue reading

HAOXI HEALTH TECHNOLOGY and Eaglepoint AI Forge Strategic Partnership to Enter AI-Powered Health Management Track

BEIJING, March 03, 2026 (GLOBE NEWSWIRE) — HAOXI HEALTH TECHNOLOGY LIMITED (NASDAQ: HAO) (the “Haoxi Health”), a U.S. publicly listed company, and Eaglepoint AI Inc., a subsidiary of Global Mofy AI Limited (NASDAQ: GMM), today jointly announced the signing of a three-year strategic cooperation agreement. The two parties will jointly commit R&D, data, and channel resources to launch an AI health management platform in China. Haoxi Health believes that this partnership marks its’s exploration of potential opportunities in the AI-enabled healthcare sector. This collaboration also represents the first time that Eaglepoint AI has deployed its Aquila data engine and multimodal model evaluation system in a high-growth health management scenario. Under the agreement, both parties will explore collaboration in the AI-enabled...

Continue reading

ZenaTech’s ZenaDrone Advances U.S. Defense and Congressional Engagement with Blue UAS-Aligned Drone Development

VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) — In light of current international events, ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today provides an update on its plans to advance engagement within the U.S. defense ecosystem and with Congressional representatives in Washington, D.C. Representatives from ZenaTech’s U.S. drone subsidiary ZenaDrone will be in Washington, D.C. later this month to meet for a second time with key Members of Congress and other stakeholders to discuss the company’s drone innovation and U.S. manufacturing plans. Emphasizing the growing importance of secure, domestically aligned unmanned aerial...

Continue reading

Jelly Toast Launches in India to Simplify Everyday Celebrations

A new app from Synchronoss designed to simplify how people celebrate and share memories BRIDGEWATER, N.J. and BANGALORE, India, March 03, 2026 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”), a global leader and innovator in personal cloud platforms, today announced the launch of Jelly Toast in India, a new app designed for shared celebrations and group memories. From birthdays and weddings to Holi gatherings, college festivals, office outings, concerts, and weekend trips, Jelly Toast creates invites, collects photos, and helps groups relive shared moments in one dedicated space. Celebrations Are Fragmented Today’s celebrations live across too many apps. Plans happen in messaging groups. Photos are shared in social media DMs. Albums sit in personal photo apps. Important moments are buried in chat...

Continue reading

Micropolis Signs $9.3 Million Commercial Development and Multi-Year Distribution Agreement with AfricAI to Expand AI-Driven Autonomous Vehicles Across Africa

New agreement includes development of three custom UGV models and exclusive regional distribution rights across key African markets DUBAI, United Arab Emirates, March 03, 2026 (GLOBE NEWSWIRE) — Micropolis Robotics (NYSE: MCRP) (“Micropolis” or the “Company”), a pioneer in unmanned ground vehicles (“UGVs”) and AI-driven autonomous mobility solutions, today announced it has signed a comprehensive commercial agreement with AfricAI Limited (“AfricAI”) that includes the development of three new customized autonomous vehicle models and a multi-year distribution agreement covering several African markets. Under the terms of the agreement, Micropolis will design, develop, test, and validate three new UGV platforms tailored specifically for African operating environments. The total contract value for the development program is approximately...

Continue reading

4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer

Seasoned biotechnology commercial leader will drive global growth strategy Commercial team further bolstered by promotions of James Vang and Jennifer Gelman to VP, Business Development and VP, Marketing, respectivelyCAMBRIDGE, UK, 3 March 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the promotion of Christine Wolosin to Chief Commercial Officer. Christine, who joined 4basebio in September 2025 as Vice President, Business Development, will lead the Company’s global commercial strategy, business development initiatives, and customer engagement as the Company scales its innovative synthetic DNA platform to serve the rapidly growing cell and gene therapy, mRNA, and vaccine markets. Christine’s promotion follows the appointment of Dr Amy Walker...

Continue reading

Marex Group plc announces fourth quarter and full year 2025 results

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) — Marex Group plc (‘Marex’ or the ‘Group’; Nasdaq: MRX) a diversified global financial services platform, providing essential liquidity, market access and infrastructure services to clients in the energy, commodities and financial markets, today reported the Group’s preliminary unaudited financial results for the fourth quarter (‘Q4 2025’). Ian Lowitt, Group Chief Executive Officer, stated, “This was a record fourth quarter for Marex, marked by a strong, broad-based performance, supportive market conditions and high levels of client activity. This included growing engagement with larger clients, which reflects our strengthening competitive position. Quarterly revenue increased 38% to $572.1 million, Adjusted Profit Before Tax¹ rose 41% to $114.9 million, and earnings per share...

Continue reading

Strata Critical Medical Announces Fourth Quarter 2025 Results

Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025 Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata’s organic growth Full year 2025 net loss from continuing operations was $20.1 million Full year 2025 revenue and Adjusted EBITDA(1) of $197.1 million and $14.1 million, respectively, both beat the high end of our guidance range Raising full year 2026 revenue guidance to between $260 and $275 million and Adjusted EBITDA guidance to between $29 and $33 million(2)NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) — Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced financial results for the fourth quarter ended December 31, 2025. Financial results in this release, including all comparisons...

Continue reading

EVgo Inc. Reports Record Fourth Quarter and Full Year 2025 Results

Total Q4 Revenues Increased 75% with Record Charging Network Revenue of $64 MillionInitiates 2026 guidance of $410 – $470 Million of Revenue and $(20) – $20 Million of Adjusted EBITDA1Total revenue of $118 million in the fourth quarter, representing an increase of 75% year-over-year. For the full year 2025, revenue reached $384 million, an increase of 50% over the full year 2024. Charging network revenue totaled a record $64 million in the fourth quarter, an increase of 37% year-over-year, representing the 16th consecutive quarter of double-digit year-over-year charging revenue growth. For the full year 2025, charging network revenue reached $218 million, an increase of 40% over the full year 2024. Network throughput reached 99 gigawatt-hours (“GWh”) in the fourth quarter, an increase of 18% year-over-year. Network throughput...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.